Shear bond strength of composite resin to titanium according to various surface treatments.
10.4047/jap.2009.1.2.68
- Author:
Seung Yun LEE
;
Mong Sook VANG
;
Hong So YANG
;
Sang Won PARK
;
Ha Ok PARK
;
Hyun Pil LIM
- Publication Type:Original Article
- Keywords:
Shear bond strength;
Surface treatment
- MeSH:
Alloys;
Calibration;
Collodion;
Crowns;
Tin;
Titanium;
Water
- From:The Journal of Advanced Prosthodontics
2009;1(2):68-74
- CountryRepublic of Korea
- Language:English
-
Abstract:
STATEMENT OF PROBLEM: When veneering composite resin-metal restoration is prepared, the fact that bond strength between Ti and composite resin is relatively weak should be considered. PURPOSE: The purpose of this study is to evaluate the shear bond strength between the veneering composite resin and commercial pure (CP) Ti / Ti-6Al-4V alloy according to the method of surface treatment. MATERIAL AND METHODS: The disks were cast by two types of metal. Their surfaces were treated by sandblasting, metal conditioner, TiN coating and silicoating respectively. After surface treatment, the disks were veneered by composite resin (Tescera(TM), Bisco, USA) which is 5 mm in diameter and 3 mm in thickness. The specimens were stored in water at 25degrees C for 24 hours, and then evaluated for their shear bond strength by universal testing machine (STM-5(R), United Calibration, USA). These values were statistically analyzed. RESULTS: 1. All methods of surface treatment were used in this study satisfied the requirements of ISO 10477 which is the standard of polymer-based crown and bridge materials. 2. The metal conditioner treated group showed the highest value in shear bond strength of CP Ti, silicoated group, TiN coated group, sandblasted group, in following order. 3. The silicoated group showed the highest value in shear bond strength of Ti-6Al-4V alloy, metal conditioner treated group, sandblasted group, TiN coated group, in following order. CONCLUSION: Within the limitations of this study, all methods of surface treatment used in this study are clinically available.
